MilliporeSigma opens $110M viral vector facility in Carlsbad, California

MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, opened a second viral vector contract development and manufacturing facility in Carlsbad, California. The $110 million, 140,000-square-foot facility doubles production capacity for viral gene therapy.

“This new $110 million, 140,000-square-foot facility will more than double the Life Science business sector's existing capacity to support large-scale commercial and industrial manufacturing for viral gene therapy.”sigmaaldrich.com

• 1 source
• sigmaaldrich.comMilliporeSigma Announces Completion of New Viral Vector ...Oct 12, 2021

Summarized from public sources; check the original articles before acting on it.